Horizon’s CEO, Joel White, recently had lunch with Peter Sullivan where he shared stories about his time working in Congress and his favorite places to go to on Capitol Hill. […]
Managed Healthcare Executive quoted Horizon’s Joel White in an article about Medicare drug price negotiations. Politico quoted Joel White, whom it identified as a Republican healthcare strategist, as saying that […]
Politico interviewed Joel White on today’s release of the ten drugs subject to government price controls and how Republicans can respond. ““The price control is a huge departure from where […]
Horizon’s CEO spoke with The Washington Times about today’s release of the ten drugs subject to Medicare price negotiations. ““It’s all wine and roses today — there’s no downside. What […]
Earlier this summer, the U.S. Department of Health and Human Services (HHS) released its final rule implementing information blocking penalties for some actors, and a rule impacting providers is expected […]
The Waste Watcher cited Horizon’s research on how pharmaceutical companies are responding to the upcoming release of the list of 10 drugs that will be subject to Medicare price negotiations. […]
Inside Health Policy spoke with Joel White about recently introduced legislation that has reporting requirements for pharmacy benefit managers, steps to keep insurers’ prior authorization in check and limits on […]
Joel White was quoted in The New York Times about the environment surrounding the upcoming list of ten drugs subject to government price controls. “Republicans opposed the drug pricing provisions, […]
Joel White spoke to Inside Health Policy about the status of legislation to make telehealth a permanent excepted benefit. Joel White, founder and president of Horizon Government Affairs, said a […]
Inside Health Policy spoke with Horizon’s Joel White about telehealth legislation working its way through Congress. Joel White, founder and president of Horizon Government Affairs, said it is important to […]